Vision Mission & Strength
R & D
Niprolac Oral Sol
Starcal D Forte
NIPRO JMI Pharma Ltd. (NJP) is contributing in developing a world-class practicein the pharma industry of Bangladesh by bridling the unment challenges in healthcare sector. It is one of the fastest growing pharmaceutical companies in Bangladesh, started its journey in 2012 with collaboration of NIPRO Corporation; a Japan based giant multinational company, a press release said.
NJP’s medicines aiding millions of diabetic, asthma patients
NIPRO JMI Pharma Limited (NJP) has introduced Linagliptin (Lijenta) and Empagliflozin (Empa), which are the breakthroughs in diabetic management and aiding millions of diabetic patients in the country....
NIPRO JMI Pharma Ltd. has celebrated Bangla New Year - 1426 at Corporate office....
Japan Bangladesh joint venture company- NIPRO JMI Pharma held its annual sales conference 2018 at International Convention City, Bashundhara, Dhaka.....
NIPRO JMI Pharma Ltd (NJPL) is one of the robust and reputed pharmaceutical companies in Bangladesh. NIPRO JMI Pharma started its journey in 2012 with collaboration of NIPRO Corporation, a big giant MNC (Multinational Company) based in Japan. We are engaged in manufacturing and marketing of pharmaceuticals products in compliance with cGMP by WHO (World Health Organization).
NJP is dedicated to ensure its world class products and services through HCP (Healthcare professional) for the ailing humanity of the country and beyond. We focus on innovative ideas into our practices. We want to make our organization a national healthcare brand with global magnitude.